000 01522 a2200481 4500
005 20250511205600.0
264 0 _c19910522
008 199105s 0 0 eng d
022 _a0264-6021
024 7 _a10.1042/bj2750099
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanger, D P
245 0 0 _aTau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
_h[electronic resource]
260 _bThe Biochemical journal
_cApr 1991
300 _a99-104 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aBlotting, Western
650 0 4 _aBrain
_xpathology
650 0 4 _aBrain Chemistry
650 0 4 _aDown Syndrome
_xmetabolism
650 0 4 _aElectrophoresis, Polyacrylamide Gel
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMicrotubule-Associated Proteins
_xchemistry
650 0 4 _aMiddle Aged
650 0 4 _aNeurofibrils
_xpathology
650 0 4 _aPhosphorylation
650 0 4 _aSolubility
650 0 4 _atau Proteins
700 1 _aBrion, J P
700 1 _aGallo, J M
700 1 _aCairns, N J
700 1 _aLuthert, P J
700 1 _aAnderton, B H
773 0 _tThe Biochemical journal
_gvol. 275 ( Pt 1)
_gp. 99-104
856 4 0 _uhttps://doi.org/10.1042/bj2750099
_zAvailable from publisher's website
999 _c1833041
_d1833041